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Abstract
Background: MicroRNAs (miRNAs) simultaneously target many transcripts through partial complementarity
binding, and have emerged as a key type of post-transcriptional regulator for gene expression. How miRNA
accomplishes its pleiotropic effects largely depends on its expression and its target repertoire. Previous studies
discovered thousands of miRNAs and numerous miRNA target genes mainly through computation and prediction
methods which produced high rates of false positive prediction. The development of Argonaute cross-linked
immunoprecipitation coupled with high-throughput sequencing (CLIP-Seq) provides a system to effectively
determine miRNA target genes. Likewise, the accuracy of dissecting the transcriptional regulation of miRNA genes
has been greatly improved by chromatin immunoprecipitation of the transcription factors coupled with
sequencing (ChIP-Seq). Elucidation of the miRNA target repertoire will provide an in-depth understanding of the
functional roles of microRNA pathways. To reliably reconstruct a miRNA-mediated regulatory network, we
established a computational framework using publicly available, sequence-based transcription factor-miRNA
databases, including ChIPBase and TransmiR for the TF-miRNA interactions, along with miRNA-target databases,
including miRTarBase, TarBase and starBase, for the miRNA-target interactions. We applied the computational
framework to elucidate the miRNA-mediated regulatory network in the Mir122a-/- mouse model, which has an
altered transcriptome and progressive liver disease.
Results: We applied our computational framework to the expression profiles of miRNA/mRNA of Mir122a-/- mutant
mice and wild-type mice. The miRNA-mediated network involves 40 curated TFs contributing to the aberrant
expression of 65 miRNAs and 723 curated miRNA target genes, of which 56% was found in the differentially-
expressed genes of Mir122a–mice. Hence, the regulatory network disclosed previously-known and also many
previously-unidentified miRNA-mediated regulations in mutant mice. Moreover, we demonstrate that loss of
imprinting at the chromosome 12qF1 region is associated with miRNA overexpression in human hepatocellular
carcinoma and stem cells, suggesting initiation of precancerous changes in young mice deficient in miR-122. A
group of 9 miRNAs was found to share miR-122 target genes, indicating synergy between miRNAs and target
genes by way of multiplicity and cooperativity.
Conclusions: The study provides significant insight into miRNA-mediated regulatory networks. Based on
experimentally verified data, this network is highly reliable and effective in revealing previously-undetermined
disease-associated molecular mechanisms. This computational framework can be applied to explore the significant
TF-miRNA-miRNA target interactions in any complex biological systems with high degrees of confidence.
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Background
Since its first discovery in Caenorhabditis elegans [1-3],
microRNA (miRNA) has been seen as a key regulator of
gene expression [4]. miRNAs are RNA molecules ranging
in size from 21 to 23 nucleotides that down-regulate
genes by guiding Argonaute (AGO) proteins to form
miRNA-induced silencing complexes (miRISC) leading
to translational repression or mRNA degradation [5].
Currently, there are 2588 mature human miRNAs (1881
precursors) and 1915 mature mouse miRNAs (1193 pre-
cursors) (miRBase 21, http://www.mirbase.org/). miRNAs
are regulated in a developmental stage-and tissue-specific
fashion [6,7] and are known to participate in diverse bio-
logical functions [8-12]. The dysregulation of miRNAs
has been correlated with the pathogenesis of various
human diseases such as cancer [13]. Cumulative evidence
has shown that, similar to protein-coding genes, miRNA
genes primarily fall under transcriptional and epigenetic
regulation [14]. With the advent of bioinformatics
and high-throughput technology, several TF-miRNA reg-
ulatory network databases have been constructed.
CircuitsDB performed human and mouse TF-miRNA
Feed-Forward regulatory Loops (FFLs) by predicting the
TF promoter and miRNA-target region [15]. Wang et al.
[14] curated studies containing approximate 5000 tran-
scription factor-miRNA regulations to create the Trans-
miR database. Yang et al. [16] integrated the high
throughput ChIP-Seq datasets to provide a web-based
tool called ChIPBase to help detect transcription factor
binding sites (TFBSs) for non-coding RNAs including
miRNAs.
The power of miRNA-target interactions (MTIs) lies in
their multiplicity and cooperativity. For nearly a decade,
MTIs were mostly obtained by way of computation and
prediction. Numerous bioinformatics tools were generated
that were based primarily on miRNA seed region comple-
mentarity with genes, free energy of miRNA-RNA duplexes,
and conservation of target sites across the species [17].
Widely used MTIs prediction tools include TargetScan
[18], miRanda [17], PicTar [19] and many others. The pace
of identification of relevant MTIs is rather slow, mostly due
to the high rate of false-positive predictions of miRNA bind-
ing sites. Rapid progress in high throughput screening
technologies such as microarrays, small RNA sequencing
(sRNA-Seq) and RNA sequencing (RNA-Seq) can expedite
MTI prediction. The most exciting breakthrough in recent
years, however, is a method which allows for the direct col-
lection of AGO-miRNA-mRNA complexes by Argonaute
cross-linked immunoprecipitation coupled with high-
throughput sequencing. This experimental approach has
advanced our understanding of MTI interactions from
prediction-based knowledge to a level that is empirically-
and genome wide-based. Representative technologies
include CLIP-Seq (cross-linking and immunoprecipitation
sequencing) [20] and CLASH sequencing (crosslinking, liga-
tion, and sequencing of hybrids) [21] which can directly
detect miRNA target sites. Meanwhile, development of the
web servers, dChip-GemiNI [22], MAGIA [23,24], and mir-
ConnX [25] provides additional tools for constructing TF-
miRNA regulatory networks through integrating gene and
miRNA expression profiles with target prediction. As a
proof-of-concept demonstration, the high-throughput tech-
niques of CLIP-Seq for miRNA-target interaction and
ChIP-Seq for TF studies were found to accelerate discovery
of TF-miRNA-gene regulatory networks in human pancrea-
tic cancer early this year [26].
While experimental-based databases have become more
popular for building gene regulatory networks, most
reconstructed TF-miRNA-gene regulation networks are
still computation/prediction-based. We expect an analysis
platform integrating high-throughput datasets from ChIP-
Seq for TF-miRNA network and CLIP-Seq and CLASH
for miRNA-Target networks could be used to effectively
explore significant TF-miRNA-MTIs interactions in any
complex biological system with improved confidence.
We applied this integrated analysis platform to the
Mir122a knockout mouse (Mir122a-/-) model of liver dis-
ease. MicroRNA-122 (miR-122) is a highly abundant,
developmental-regulated, liver-specific miRNA. It plays a
pivotal role in maintaining lipid metabolism homeostasis
[27,28] and tumor suppression in the liver [29,30].
Mir122a knockout mice (Mir122a-/-) develop tempo-
rally-controlled steatohepatitis, fibrosis and hepatocellu-
lar carcinoma (HCC), a path similar to the disease
progression in humans [31,32]. A striking feature of this
mouse model is that miR-122a profoundly modulates the
liver transcriptome. The pathway disturbances that might
drive cancer initiation and progression are found in
young Mir122a-/- mice (2-months old). To date we have
detected the expression of 79 experimentally-verified
miR-122 targets, which represents only 8.9% (79/886) of
the differentially expressed genes (DEGs) [32] in
Mir122a-/- livers. Since miR-122 represents ~70% of the
liver miRNAs, the imbalance of the miRNA homeostasis
in Mir122a-/- liver can give rise to liver damage. A sys-
tematic, genome-wide investigation of the miRNA-
mediated regulatory networks will provide important
insights into the molecular mechanisms by which miR-
122 modulates liver transcriptome and disease.
Results
We reconstructed the miRNA-mediated regulatory net-
work in mouse livers using high-throughput expression
profiles. The overview is shown in Figure 1. First, we
identified DEGs by retrieving the multiple gene microar-
ray datasets from GEO (GSE27713). High-confidence dif-
ferentially expressed miRNAs (DEmiRs) were derived
from the intersection of two miRNA expression profiles
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(OpenArray and small RNA-Seq). Second, we mapped
the DEGs and DEmiRs to the curated TF-miRNA regula-
tory network as active nodes and removed the other non-
mapping nodes. Finally, we reconstructed the potential
miRNA-mediated regulatory network in Mir122a-/-
mouse livers.
Differential expression of miRNAs in Mir122a-/- mice
To obtain a list of high confidence DEmiRs in Mir122a-/-
mouse livers, we subjected the same pair of wild-type
(WT) and Mir122a-/- mouse liver samples to small RNA
sequencing and OpenArray assay for miRNA profiling.
The profiling results from these two entirely different plat-
forms showed a positive correlation (R = 0.7). For each
profiling technology, we selected DEmiRs (see the Method
section). Considering that different platforms have differ-
ent coverage for all mouse miRNAs, we focus on the
DEmiRs presented by both small RNA-Seq and OpenAr-
ray assay. We identified 48 up-regulated miRNAs
(UPmiRs) and 17 down-regulated miRNAs (DNmiRs) in
Mir122a-/- mouse livers. Among the UPmiRs, expression
of 41 miRNAs (85%) was highly elevated while 7 others
showed moderate increase in expression (Table 1). We
studied the chromosomal locations and found that,
remarkably, the group of 41 highly expressed UPmiRs
is located in the imprinted Dlk1-Dio3 gene cluster on
the mouse chromosome 12qF1 region (Chr12qF1). In
contrast, only 1 DNmiR (6%) was located in the Chr12qF1
region. No preferred chromosomal locations were assigned
to those moderately increased UPmiRs and other DNmiRs.
We speculate that the promoter regions of Chr12qF1-
DEmiRs operate under a similar mode of transcription
regulation. We further investigated the TF-miRNA regula-
tion to support our speculation.
Potential TF-miRNA regulatory networks in Mir122a-/-
mice
To understand whether these DEmiRs are transcriptionally
regulated by specific transcription factors in Mir122a-/-
mice, we reconstructed the TF-miRNA regulatory networks
by integrating two experimentally verified resources, ChIP-
Base [16] and TransmiR [14]. ChIPBase is a comprehensive
resource which includes annotated 7306 TF-miRNA rela-
tionships from 119 mouse ChIP experiments targeting
73 TFs. We identified a total of 240 TF-miRNA interactions
involving 40 TFs and 65 DEmiRs. The TF-DEmiRs regula-
tory network in the Mir122a-/- hepatocyte is presented in
Figure 2 and detailed TF-DEmiRs interactions are listed in
Tables S2.1 and S2.2. The results showed that, similar to
the majority of the pol II genes, one miRNA can be regu-
lated by different TFs (Table S2.1) and one specific TF
can modulate the expression of multiple target miRNAs
(Table S2.2). Ten of the 40 curated TFs, potentially regulat-
ing 46 miRNAs, are verified as miR-122 target genes. CTCF
Figure 1 Overview of the computational framework for reconstructing the miRNA-mediated regulatory network.
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Table 1 List of differentially expressed miRNAs common to both OpenArray analysis and miRNA-Seq
Category miRNA miRNA loci miRNA-Seq OpenArray
miR-429-3p chr4:156053905-156053987:- 2.01 3.56E+00
miR-200a-3p chr4:156054896-156054985:- 2.50 2.25E+00
miR-200b-3p chr4:156055681-156055750:- 3.53 4.25E+00
miR-200c-3p chr6:124718322-124718390:- 1.86 2.88E+00
miR-182-5p chr6:30165918-30165992:- 2.12 2.41E+00
miR-326-3p chr7:99552269-99552363:+ 2.07 1.83E+00
miR-199a-5p chr9:21496495-21496564:- 3.39 1.10E+01
miR-673-3p chr12: 109571990-109572080:+ 34.09 3.55E+04
miR-337-3p chr12: 109585789-109585885:+ 22.14 9.67E+00
miR-337-5p chr12: 109585789-109585885:+ 59.88 2.20E+01
miR-540-3p chr12: 109586080-109586146:+ 26.89 1.04E+04
miR-431-5p chr12: 109590447-109590537:+ 34.02 5.96E+05
miR-127-3p chr12: 109592846-109592915:+ 61.60 1.59E+01
miR-127-5p chr12: 109592846-109592915:+ 38.92 3.07E+01
miR-434-3p chr12: 109594506-109594599:+ 68.55 2.98E+01
miR-434-5p chr12: 109594506-109594599:+ 49.12 2.35E+01
miR-136-3p chr12:109595327-109595388:+ 55.82 1.29E+01
miR-136-5p chr12:109595327-109595388:+ 42.94 2.49E+00
miR-379-5p chr12:109709060-109709125:+ 46.48 1.74E+01
miR-379-3p chr12:109709060-109709125:+ 62.39 7.18E+00
miR-411-3p chr12:109710175-109710256:+ 64.08 1.16E+01
miR-411-5p chr12:109710175-109710256:+ 56.88 2.51E+01
Up-regulated miR-299a-5p chr12:109710638-109710700:+ 34.89 6.81E+02
miR-329-3p chr12:109713481-109713577:+ 19.84 1.05E+04
miR-494-3p chr12:109715318-109715402:+ 16.36 1.35E+03
miR-1193-3p chr12:109715671-109715791:+ 33.38 1.07E+01
miR-543-3p chr12:109717258-109717333:+ 28.07 5.30E+00
miR-495-3p chr12:109718754-109718816:+ 31.35 2.03E+01
miR-376c-3p chr12:109722718-109722803:+ 43.62 1.85E+01
miR-376b-3p chr12:109723458-109723539:+ 64.47 4.21E+01
miR-376b-5p chr12:109723458-109723539:+ 56.26 2.81E+01
miR-376a-3p chr12:109723781-109723848:+ 12.12 2.07E+04
miR-300-3p chr12:109724313-109724391:+ 48.31 2.87E+03
miR-381-3p chr12:109726822-109726896:+ 59.30 2.33E+03
miR-382-5p chr12:109733771-109733846:+ 26.07 4.62E+00
miR-382-3p chr12:109733771-109733846:+ 16.26 4.37E+03
miR-134-5p chr12:109734139-109734209:+ 41.55 3.29E+01
miR-485-5p chr12:109734902-109734974:+ 10.71 1.18E+05
miR-485-3p chr12:109734902-109734974:+ 63.49 9.91E+01
miR-154-3p chr12:109738433-109738498:+ 63.36 8.38E+01
miR-154-5p chr12:109738433-109738498:+ 57.20 4.12E+03
miR-496a-3p chr12:109739119-109739197:+ 48.48 5.39E+03
miR-541-5p chr12:109742409-109742498:+ 48.98 4.90E+01
miR-409-5p chr12:109743158-109743236:+ 16.22 7.26E+03
miR-409-3p chr12:109743158-109743236:+ 58.62 2.91E+01
miR-369-3p chr12:109743418-109743496:+ 19.52 1.03E+04
miR-369-5p chr12:109743418-109743496:+ 7.92 2.19E+03
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Table 1 List of differentially expressed miRNAs common to both OpenArray analysis and miRNA-Seq (Continued)
miR-410-3p chr12:109743715-109743795:+ 51.74 9.52E+00
Down-regulated miR-455-3p chr4:63256851-63256932:+ 0.64 4.35E-01
miR-455-5p chr4:63256851-63256932:+ 0.66 3.85E-01
miR-31-3p chr4:88910557-88910662:- 0.40 9.54E-02
miR-31-5p chr4:88910557-88910662:- 0.25 8.27E-02
miR-93-5p chr5:138165523-138165610:- 0.58 9.70E-04
miR-339-3p chr5:139369650-139369745:- 0.57 2.59E-01
miR-335-5p chr6:30741299-30741396:+ 0.41 3.99E-01
miR-486b-5p chr8: 23142573-23142662:- 0.50 3.09E-01
miR-144-3p chr11:78073005-78073070:+ 0.46 1.83E-01
miR-451a chr11:78073170-78073241:+ 0.35 7.81E-03
miR-345-5p chr12:108836973-108837068:+ 0.52 3.19E-01
miR-17-5p chr14:115043671-115043754:+ 0.55 2.16E-07
miR-19a-3p chr14:115044000-115044081:+ 0.35 4.21E-01
miR-484 chr16:14159626-14159692:+ 0.59 6.05E-01
miR-802-5p chr16:93369720-93369816:+ 0.17 7.01E-02
miR-145a-5p chr18:61647825-61647894:- 0.56 1.95E-01
miR-322-5p chrX:53054255-53054349:- 0.61 4.79E-01
There are 48 up-regulated and 17 down-regulated miRNAs in 2-month-old male Mir122a-/- (KO) and WT mice. The expression ratio between the mir-122-/- and WT
(KO/WT) is shown.
Figure 2 TF-miRNA regulatory network. A total of 240 TF-miRNA interactions involving 40 TFs and 65 DEmiRs were collected for this network,
with transcription factor Spi1 and Ctcf binding directly to the promoters of numerous miRNAs. Most of the UPmiRs (41 miRNAs) regulated by
Ctcf and Spi1 are located in Chr12qF1. The octagonal nodes represent the transcription factors (TF) and the V-shaped nodes correspond to the
miRNAs, while the nodes marked by the blue border represent the miR-122 targets. The up-regulated miRNAs/TFs are marked in red; down-
regulated miRNAs/TFs are marked in green; TFs showing no differential expression are marked in grey.
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[33] is a miR-122 target gene found in the human HCC cell
line, while Hif1a [34] is a recently confirmed miR-122a tar-
get in mouse hepatocytes. Although the target relationship
of miR-122 with EZH2, MYCBP, RBBP5, SIN3A, SIN3B,
SIRT1, SRF and SUZ12 has not been studied in mouse liver
but it has been identified in starBase with human samples.
The fact that many target genes of miR-122 are common to
both mouse and human it is highly likely that EZH2,
MYCBP, RBBP5, SIN3A, SIN3B, SIRT1, SRF and SUZ12
are mouse miR-122a target genes. This result suggests that
miR-122 can potentially modulate the expression of 46
miRNAs via its target transcription factors.
The appearance of higher numbers of connections in
some hub-TFs and hub-DEmiRs suggests that these
hub-TFs may play an essential role in the regulation of
multiple DEmiRs, and that the hub-DEmiRs could
potentially be regulated by multiple TFs in a combina-
torial mode. For example, spleen focus forming virus
(SFFV) proviral integration oncogene (Spi1) and
CCCTC-binding factor (Ctcf) are the top two hub-TFs
(Figure 2). The expression level of both Spi1 and Ctcf is
moderately increased (1.3-1.4 fold) in Mir122a-/- mice.
Ctcf can perhaps regulate 42 DEmiRs including 32
UPmiRs and 10 DNmiRs. Most of the Ctcf-UPmiRs
(94%) are located in Chr12qF1 locus. Spi1 could poten-
tially regulate 23 DEmiRs (15 UPmiRs with 12 miRNAs
in Chr12qF1 and 8 DNmiRs). Our analysis also suggests
that 6 DEmiRs, miR-17-5p, miR-486b-5p, miR-19a-3p,
miR-484, miR-199a-5p and miR-182-5p, are likely to be
co-regulated by both Ctcf and Spi1. Further experimen-
tation is needed to support these initial findings. It is
interesting to note that Spi1-UPmiRs and Ctcf-UPmiRs
are respectively clustered within different regions of
Chr12qF1, namely the Meg3-Rian region and Mirg
region.
Network analysis of curated miRNA target genes
Since 21 DEmiRs have no known validated targets (Table
S3.1), we collected the interactions of 44 DEmiRs and
2,315 DEGs to establish the miRNA-target regulatory
network. Table 2 shows detailed statistics of the curated
MTIs. A total of 1,067 interactions between the 44
DEmiRs and 723 curated target genes were obtained.
There are 460 up-regulated and 263 down-regulated
genes in the group of 723 curated targets. A total of 499
targets (295 up-regulated and 204 down-regulated) are
present in the group of 886 DEGs found in 2-month old
Mir122a-/- mice livers [32]. We were surprised to find
that 56% (499/886) of DEGs in Mir122a-/- mice livers are
likely modulated by dysregulated miRNAs. Figures 3 and
4 respectively present the UPmiRs-regulatory network
(536 interactions between the 33 UPmiRs and the 204
DEGs) and the DNmiRs-regulatory network (531 interac-
tions between the 11 DNmiRs and 295 DEGs). The
regulator hub-DEmiRs in the two networks are miR-381-
3p and miR-17-5p, respectively. Moreover, down-regu-
lated Nfib and up-regulated Trp53inp1 are the miRNA
target hubs (Table S3.2).
The complex interplay of miRNAs and target genes is
accomplished through multiplicity and cooperativity. We
identified 9 DEmiRs that can simultaneously regulate 39
miR-122 targets (Table S4.1, S4.2). A priori., we reasoned
that in Mir122a-/- livers, elevated expression of Klf6, a
miR-122 target gene [32], is a simple response to the loss
of miR-122a; nonetheless, elevated expression of Klf6 is
likely to be the sum of a cascade of events involving the
loss of miR-122a and the down regulation of 5 other
DNmiRs (miR-17-5, -31, 19a, 93-5p and 144-3p). Our
analysis supports the conclusion that miRNAs and tran-
scription factors are two major classes of gene regulators
using similar control principles, namely one-to-many and
many-to-one relationships between the regulator and the
target genes [17].
The differentially expressed target genes were analyzed
using Ingenuity Pathway Analysis (IPA). Selected molecu-
lar and cellular functions significantly enriched in the
DEGs under the categories of “Diseases and Biological
Functions” and “Canonical Pathways” are respectively
listed in Tables 3 and 4, while Tables S5.1 and S5.2 respec-
tively provide detailed gene lists. As shown in Figure 5, dif-
ferent functional enrichment in the category of “Diseases
and Functions” was identified for the target genes of
UPmiRs and DNmiRs. The functions of the UPmiR-targets
are involved in the negative regulation of lipid metabolism,
energy production, and RNA processing. They also contri-
bute to connective tissue disorders and metabolic disease.
In contrast, the functional roles of the DNmiR-targets are
significantly associated with the promotion of cell cycles,
tissue development and cell-to-cell signalling.
To further understand their functional involvement, the
group of differentially expressed target genes was used for
IPA Canonical Pathway analysis. As shown in Figure 6, dif-
ferent functional enrichment was assigned to the target
genes of UPmiRs and DNmiRs. The UPmiR-targets are
involved in the negative regulation of the biosynthesis of
macromolecules, while the DNmiR-targets participates in
various cell signalling pathways for cell adhesion, prolifera-
tion, cell transformation and hepatic fibrosis. Highly signifi-
cant enriched pathways such as signalling for actin
cytoskeleton/actin-based mobility by Rho, hepatic stellate
cell activation, PKA signalling, ERK signalling, PTEN sig-
nalling and NF-B signalling, were enriched only for
DNmiR-targets. The IPA analysis results strongly suggest
that UPmiRs-targets are involved in loss-of-function activ-
ities, while DNmiRs-targets work in a gain-of-function
manner. Figure S2.1-S2.22 and S3.1-S3.19 respectively
show the pathway presentation of the Causal Network Ana-
lysis of “Diseases and Functions” and “Canonical Pathways”.
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Table 2 Statistics for curated miRNA-target interactions
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Discussion
In this case study we analyzed the miRNA-mediated
regulatory network in Mir122a-/- mouse livers and iden-
tified a complex interplay of TF-miRNA and miRNA-
targets by way of multiplicity and cooperativity. Using
similar control principles, TF and miRNA can jointly
fine-tune the target gene expression. The results of this
study showed that altered expression of miRNAs in
miR-122a-deficient livers had far-reaching effects on
liver homeostasis. Previously we demonstrated that
fibrotic and tumor signature genes were induced early
in Mir122a deficient livers [32]. The current study pro-
vided additional new evidence to reveal that the inter-
play between differentially expressed miRNAs and their
target genes not only contributes greatly to the proper-
ties we previously characterized but also raised new
activities to assist the process of cell transformation of
Mir122a-/- hepatocytes. A general theme of DEmiR-tar-
get interaction is that UPmiRs-targets are involved in
loss-of-function activities while DNmiRs-targets contri-
bute to gain-of-function activities.
In the absence of the abundant liver-specific miR-
122a, the altered expression of DEmiRs did not reinstate
the normal physiological functions of miR-122a, but
rather expedited the hepatocyte de-differentiation. Sev-
eral lines of evidence supported our observation. (1)
DEmiRs synergistically heighten the adverse effect of
miR-122a deficiency. We found a group of 9 DNmiRs
that can potentially target 39 miR-122a target genes.
These 9 DNmiRs are miR-144-3p, 17-5p, 93-5p, 322-5p,
19a-3p, 31-5p, 145a-5p, 335-5p and 345-5p (Tables S4.1
and S4.2). miR-144-3p and miR-17-5p can respectively
recognize 19 and 17 miR-122a targets. Upregulation of
the miR-122a-co-targets contribute to altered cell adhe-
sion, cytoskeleton organization, protein phosphorylation,
ion transport, glucose catabolic process and liver fibro-
sis. (2) Induced expression of Chr12qF1 miRNAs was
detected in mutant hepatocytes. The imprinted Dlk1-
Dio3 gene cluster is located on mouse chromosome 12
(12qF1) and human chromosome14 (14q32.2). Concur-
rent overexpression of Chr12qF1 miRNAs is regarded as
the miRNA signature of the stem cell property [35,36]
and overexpression of 14q32.2 miRNAs has been
detected in cancer stem cells and in aggressive types of
human HCC [37] as well as in other cancer types [38].
(3) Upregulation of several UPmiRs has been reported
in HCC despite the fact the 2-month old Mir122a-/-
livers are free of tumors. Elevated expression of miR-
182 [39], miR-429 [40], miR-199a, 199a*, 200a, and
200b was positively and significantly correlated to the
progression of liver fibrosis [41]. These results reinforce
our previous findings that dysregulation of liver func-
tions begins in young Mir122a-/- mice [32].
Table 2 Statistics for curated miRNA-target interactions (Continued)
miR-410-3p 524 29

















Total 65 DemiRsa 4,220b* 499c,*
a includes 48 up-regulated miRNAs and 17 down-regulated miRNAs
b includes 460 up-regulated target genes and 263 down-regulated target genes, for a total of 723 genes.
c includes 295 up-regulated genes and 204 down-regulated genes of the 886 differentially-expressed genes found in 2-month old Mir122a-/- mouse livers [32].
* indicates the unique gene count
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In Mir122a-/- livers, overexpression of several classic
imprinted genes H19, Igf2, Meg3, Mirg and Rian signals
for altered epigenetic regulation. How miR-122 influ-
ences epigenetic regulation of DEGs is not clear. It has
been reported that many miRNA targets are involved in
gene regulation at the epigenetic level [42]. From the
curated miRNA-target interactions, several enzymes
affecting methylation of DNA or histones were found to
be the target genes of UPmiRs. Tet methylcytosine diox-
ygenase 2 (Tet2), lysine (K)-specific demethylase 7A
(Kdm7a) and jumonji domain containing 1C (Jmjd1c, a
H3K9 demethylase) are respectively targeted by 8, 9 and
5 UPmiRs (Table S3.2). Whether reduced expression of
these enzymes is linked to epigenetic regulation of
DEGs in Mir122a-/- mice requires further experimental
demonstration. It is worth mentioning that CTCF, an
insulator-and chromatin loop-associated protein as well
as an epigenetic regulator, is a direct target of miR-122
[33].
TF-DEmiR interactions revealed that Ctcf, a hub-TF,
potentially can regulate 42 DEmiRs including 32
UPmiRs and 10 DNmiRs. A great proportion of the
Ctcf-UPmiRs (94%) is located in the Chr12qF1 locus.
Recently, CTCF was found to be involved in the regula-
tion of miR-125b1, miR-375, and the miR-290 cluster in
breast cancer cells and stem cells [43]. DNA methylation
seems to play a role in the CTCF regulation of miRNAs
since CTCF binding sites tend to be mapped to the
hypomethylated regions [44]. Our initial methylome
data also showed that the Ctcf binding sites in the
Figure 3 UPmiRs regulatory network. This network involves 536 interactions between 33 UPmiRs and 204 DEGs. Fifteen of the 48 UPmiRs did
not have known validated targets (Table 2). The regulator hub-UPmiR is miR-381-3p which has 45 target genes (Table S3.1). Down-regulated
Nfib being targeted by 12 UPmiRs (Table S3.2) is the miRNA target hub. The background of hub-miRNAs/genes is marked in purple. The V-
shaped nodes correspond to the miRNAs, while the rectangle-shaped nodes are the target genes. The up-regulated miRNAs/genes are marked
in red; down-regulated miRNAs/genes are marked in green. Regulatory effects are illustrated as blunt ends (⊥) between miRNAs and genes.
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Figure 4 DNmiRs regulatory network. This network involves 531 interactions between 11 DNmiRs and 295 DEGs. Six of the 17 DNmiRs did
not have known validated targets (Table 2). The regulator hub-DNmiR is miR-17-5p which has 115 target genes (Table S3.1). Up-regulated
Trp53inp1 being targeted by 7 DNmiRs (Table S3.2) is the miRNA target hub. The background of hub-miRNAs/genes is marked in purple. The V-
shaped nodes correspond to the miRNAs, while the rectangle-shaped nodes are the target genes, the nodes marked by the blue border
represent the co-miR-122 targets, and the octagonal nodes represent the transcription factors (TF). The up-regulated miRNAs/genes are marked
in red; down-regulated miRNAs/genes are marked in green. Regulatory effects are illustrated as blunt ends (⊥) between miRNAs and genes.
Table 3 Functional analysis of 204 down-regulated target genes of UPmiRs and 295 up-regulated target genes of
DNmiRs in IPA “Diseases and Functions”
Diseases and Functions UPmiRs DNmiRs
p value Count p value Count
Lipid Metabolism 3.85E-06 22
Cellular Growth and Proliferation 9.18E-06 26 5.17E-10 77
Connective Tissue Disorders 1.12E-04 11
Energy Production 5.59E-04 5
Metabolic Disease 8.11E-04 8
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Table 3 Functional analysis of 204 down-regulated target genes of UPmiRs and 295 up-regulated target genes of
DNmiRs in IPA “Diseases and Functions” (Continued)
RNA Post-Transcriptional Modification 1.10E-03 3
Nervous System Development and Function 1.57E-03 25 5.27E-28 61
Tissue Development 1.60E-03 34 6.33E-29 96
Cell-To-Cell Signaling and Interaction 1.64E-03 12 6.33E-29 54
Cell Death and Survival 4.27E-03 12 4.85E-24 105
Cellular Assembly and Organization 4.68E-03 17 6.33E-29 65
Cellular Movement 6.92E-03 6 4.52E-09 58
Cell Cycle 1.06E-02 4 2.28E-07 32
Organismal Survival 1.82E-11 99
Total number of UPmiR-targets: 57
Total number of DNmiR-targets: 168
Table 4 Function analysis of 204 down-regulated target genes of UPmiRs and 295 up-regulated target genes of
DNmiRs in IPA “Canonical Pathways”
Ingenuity Canonical Pathways UPmiRs DNmiRs
p value Count p value Count
Superpathway of Cholesterol Biosynthesis 8.51E-06 5
Glycogen Biosynthesis II (from UDP-D-Glucose) 1.10E-03 2
Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I 2.09E-02 2
Regulation of the Epithelial-Mesenchymal Transition Pathway 4.57E-02 5 7.76E-02 6
Leukocyte Extravasation Signaling 5.50E-02 5 4.17E-03 9
Integrin Signaling 5.50E-02 5 7.59E-05 12
PDGF Signaling 1.98E-01 2 2.51E-04 7
CXCR4 Signaling 2.12E-01 3 3.02E-03 8
PAK Signaling 2.29E-01 3 2.57E-03 6
p53 Signaling 2.64E-01 3 4.27E-03 6
IGF-1 Signaling 2.64E-01 3 2.19E-05 9
p70S6K Signaling 3.54E-01 3 1.20E-02 6
RhoA Signaling 3.54E-01 3 2.95E-03 7
Axonal Guidance Signaling 4.68E-01 5 5.50E-04 17
Molecular Mechanisms of Cancer 5.28E-01 4 2.14E-03 14
NRF2-mediated Oxidative Stress Response 5.42E-01 2 1.86E-03 9
STAT3 Pathway 5.42E-01 1 1.78E-04 7
TGF-P Signaling 5.98E-01 1 7.08E-05 8
Glioma Signaling 6.35E-01 1 8.32E-04 7
Actin Cytoskeleton Signaling 6.76E-03 9
Hepatic Fibrosis/Hepatic Stellate Cell Activation 2.82E-04 11
Protein Kinase A Signaling 9.33E-04 15
ERK/MAPK Signaling 8.91E-03 8
PTEN Signaling 6.03E-04 8
NF-B Signaling 5.37E-03 8
Regulation of Actin-based Motility by Rho 2.45E-03 6
Cell Cycle: G2/M DNA Damage Checkpoint Regulation 8.13E-03 4
Total number of UPmiR-targets: 29
Total number of DNmiR-targets: 76
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Chr12qF1 locus are less methylated in Mir122a-/- than
in the WT liver (data not shown).
Conclusions
We applied our computational framework to the expres-
sion profiles of the miRNA/mRNA from Mir122a-/-
mutant mice and wild-type mice and found a miRNA-
mediated network involving 40 curated TFs regulating
the aberrant expression of 65 miRNAs and 723 curated
miRNA target genes, of which 56% was found in the dif-
ferentially expressed genes of Mir122a-/- mice. This regu-
latory network disclosed previously known as well as
many previously unidentified miRNA-mediated regula-
tions in mutant mice. Remarkably, we demonstrate that
loss of imprinting at 12qF1 is associated with miRNA
overexpression in human HCC and stem cells, suggesting
initiation of precancerous changes in young mice defi-
cient in miR-122. In addition, a group of 9 miRNAs was
found to share miR-122 target genes, indicating synergy
between miRNAs and target genes by way of multiplicity
and cooperativity. These findings have a potentially sig-
nificant impact on our understanding of miRNA-
mediated regulatory networks. By collectively utilizing
the experimentally verified data, this computational fra-
mework is highly reliable, effective and is suitable for
exploring significant TF-miRNA-miRNA target interac-
tions in any complex biological system.
Methods
Computational framework for reconstructing the miRNA-
mediated regulatory network
Figure 1 presents an overview of the proposed computa-
tional framework to reconstruct the miRNA regulatory
network. We obtained mouse TF-miRNA regulation infor-
mation from TransmiR and ChIPBase and those regula-
tions related to differentially expressed miRNAs in the
livers of Mir122a-/- and wild type mice were selected. The
differentially expressed miRNAs were determined by
expression profiles using the OpenArray system and small
RNA-Seq. The differentially expressed genes were identified
from the expression profiles using gene chips. Moreover,
we integrated experimental miRNA-target gene interactions
from miRTarBase, TarBase and starBase. For each miRNA-
target interaction, miRNA and its target gene with inverse
expression level were selected for further reconstruction of
the miRNA-mediated regulatory network.
Figure 5 The target genes of UPmiRs and DNmiRs display distinct functional enrichment in the category of “Diseases and Functions”.
The functions of the UPmiR-targets are involved in the lipid metabolism and RNA processing while the DNmiR-targets are related to cell growth,
cell cycle, tissue development, cell-to-cell signalling and cell survival. The threshold significance level is set at p < 0.05.
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Curated TF-miRNA interactions and construction of the
TF-miRNA regulatory network
To reconstruct the high confidence TF-miRNA regulatory
network in Mir122a-/- mice, we integrated two experimen-
tally verified resources, TransmiR (version 1.2) [14] and
ChIPBase (release 1.1) [16], to support the regulations in
TF-miRNA. TransmiR is the TF-miRNA interaction data-
base, and contains 735 manually curated TF-miRNA regu-
latory interactions. ChIPBase provides the transcriptional
regulation not only for the protein-coding genes, but also
for non-coding RNA (including miRNA) from ChIP-Seq
data. The miRNA promoter region used in this study is
defined as a 5 kb upstream region and 1 kb downstream
region. Transcription factor binding sites (TFBSs) from
ChIP-Seq data on each miRNA promoter provide empiri-
cal evidence of TF-miRNA interactions. Table S1 sum-
marizes the 8,697 curated TF-miRNA interactions
between 73 TFs and 964 miRNAs in mouse livers. The
TF-miRNA regulatory network was constructed based on
the interactions between differentially expressed miRNAs
and their experimentally verified TFs. We used Cytoscape
(version 3.1.1) [45-48] to visualize the TF-miRNA regula-
tory network.
Curated miRNA-target interactions and construction of
the miRNA-target regulatory network
To construct the miRNA-mediated regulatory network in
Mir122a-/- mice, we collected datasets of experimentally
validated miRNA-target interactions (MTIs) from miR-
TarBase [49], TarBase [50] and starBase [51]. The miR-
TarBase release 4.5 dataset http://mirtarbase.mbc.nctu.
edu.tw contains more than fifty thousand miRNA-target
interactions, obtained by manually surveying the relevant
literature using textual data mining tools to systemati-
cally filter research articles related to functional studies
of miRNAs. Generally, the collected MTIs have been vali-
dated experimentally by 3’UTR-reporter assay, western
blotting, microarray analysis and by next-generation
sequencing experiments. TarBase (version 6) is the other
data source for obtaining the experimentally validated
MTIs. This work not only integrated the MTIs from
miRTarBase and TarBase, we also collected MTIs from
Argonaute CLIP-Seq data. starBase is a database used for
deciphering miRNA-target interactions accumulated
from 108 CLIP-Seq data from 37 studies. For this study,
we retrieved MTIs only from data derived from mouse
tissue. Table S1 summarizes the relationships among the
Figure 6 The target genes of UPmiRs and DNmiRs display distinct functional enrichment in the category of “Canonical Pathway”. The
functions of the UPmiR-targets are involved in biosynthesis of macromolecules while the DNmiR-targets participate in various cell signalling
pathways for cell adhesion, proliferation, cell transformation and hepatic fibrosis. The threshold significance level is set at p < 0.05.
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95,364 curated MTIs between 329 miRNAs and 7,001
target genes.
To construct the miRNA-target regulatory network, we
gathered the DEmiRs and DEGs respectively from the
miRNA expression profiles (OpenArray and small RNA-
Seq) and microarray datasets. We identified the tran-
scriptional regulation and the post-transcription regula-
tion of DEmiRs from experimentally verified resources.
An inverse relationship in expression was often found
between miRNAs and their target genes [52-55], thus we
focused on those inversely correlated pairs of DEmiRs
and the curated targets. For each up-regulated miRNA,
the curated target genes are down-regulated and vice
versa. These interactions are imported to Cytoscape for
visualizing the miRNA-target regulatory network.
Functional and pathway analysis using Ingenuity Pathway
Analysis (IPA)
To discuss the TF-miRNA regulatory network, we analyzed
the target genes of differentially expressed miRNAs using
Ingenuity Pathways Analysis 2014 (IPA Summer Release
2014, Ingenuity Systems, http://www.ingenuity.com). IPA
analysis identified biological functions and canonical path-
ways related to the targets of up-and down-regulated miR-
NAs and enabled comparison across multiple analyses with
varying conditions. A threshold was set at p value 0.05
which was calculated by Fisher’s exact test. Causal Network
Analysis provides the causal connections between diseases,
genes and networks of upstream regulators [56].
RNA isolation, gene expression, and high-density
oligonucleotide microarray analysis
Total RNA was isolated from the liver samples of wild-type
mice andMir122a-/- mice using the Trizol reagent (Invitro-
gen) according to the manufacturer’s protocol. The micro-
array hybridizations were performed using total RNA
prepared from the liver samples of three wild-type mice
and four Mir122a-/- mice at an age of 2-months. GeneChip
Mouse Genome 430 2.0 Affymetrix oligonucleotide Gene
Chips (Affymetrix) were analyzed at the Microarray &
Gene Expression Analysis Core Facility (VGH-YM Gen-
ome Center, National Yang-Ming University) according to
the Affymetrix protocols. All the data files are presented in
compliance with MIAMI guidelines and can be accessed
online at the Gene Expression Omnibus (series accession
numbers GSE27713 [32]). A total of 2315 differentially
expressed genes was identified in the Mir122a-/- mice,
1,448 genes up-regulated (a fold change of ≥ 1.5) and 867
genes down-regulated (a fold change of ≤ 0.66).
miRNA Profiling on high-throughput OpenArray™ system
MiRNA expression profiling of the liver sample from
one wild-type mouse and one Mir122a-/- mouse (both
2-months old) was performed using TaqMan Rodent
MicroRNA Array v2.0 (Applied Biosystems) according
to the manufacturer’s instructions. This array panel
enables the simultaneous quantification of the expres-
sion of 750 rodent (mouse and rat) well-characterized
mature miRNAs. All the mature miRNA names are
mapped to the name recorded in miRBase V20. Expres-
sion data were processed using OpenArray™ Real-Time
qPCR Analysis Software. The data were further analyzed
in HTqPCR package from Bioconductor (v2.1.2) in R
2.23. Data were quantile normalized and duplicates aver-
aged using U6 rRNA as an endogenous control. Unde-
termined miRNAs or those with a Ct value below 15 or
greater than 35 across all samples were removed from
subsequent analysis. We set the cut-off for the up-regu-
lated miRNAs with ≥ 1.5 fold change, or ≤ 0.66 for
down-regulated miRNAs.
Small RNA-Seq data analysis
The same liver samples that were analysed by OpenAr-
ray™ system were further subjected to small RNA sequen-
cing. The sequencing libraries for miRNA-Seq were
prepared using TruSeq Small RNA Sample Preparation
Kit (Illumina) according to the manufacturer’s instruction.
One microgram of total RNA with an RNA integrity num-
ber (RIN) greater than 8.0 was ligated sequentially to 3’
and 5’ adaptors. Subsequently, the ligation product was
reverse transcribed followed by PCR for 11 cycles
to enrich miRNAs that have adapter sequences on both
ends. The amplified cDNA construct was size fractionated
(145-160 bp) and purified by 6% Novex TBE PAGE gel
(Invitrogen). The miRNA library was quantified by qPCR
and the size distribution was validated on a 2100 Bioanaly-
zer (Agilent) by a High Sensitivity DNA chip. The miRNA
library was sequenced on a HiSeq 2000 (Illumina) by sin-
gle end sequencing with a 50 bp read length.
Raw sequencing reads were quality pre-processed using
the FASTX-Toolkit [57] version 0.0.13 as follows. First, the
Illumina 3’ adapter sequences ‘TGGAATTCTCGGGTGC-
CAAGG’ were removed. The reads were then trimmed
according to their quality values based on the Phred quality
score. We set a Phred quality score of 20 as the cut-off
value. We obtained the small RNA reads if the reads were
longer than 18 nucleotides and shorter than 30 nucleotides.
We then used the ncPRO-seq [58] package (version 1.5.1),
a bowtie-based [59] read alignment tool for the annotation
reads, to confirm the read distribution in the reference
genome. Only reads that mapped a maximum of two mis-
matches and 20 locations in the genome were used (bowtie
parameter: -v2 -a -m20 –best –strata –nomaqround -f -y).
Five main databases were employed to annotate the small
RNA distribution: the UCSC reference genome (mm10),
miRBase v20 [60,61], UCSC refGene 06-Apr-2014, RFam
v11.0 [62], and UCSC repeatMasks (mm10). To quantify
the miRNA profiles, we used miRDeep2 [63,64] package
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(version 2.0.0.5), another bowtie-based alignment tool.
Figure S1 shows that more than 65% of small RNA reads
were miRNAs, indicating that our small RNA reads were
highly enriched for miRNAs. The miRNAs were identified
as significantly differentially expressed as compared to
those in normal livers if the fold change was greater than
or equal to 1.5 (up-regulated miRNAs) or the fold change
was less than or equal to 0.66 (down-regulated miRNAs).
Additional material
Additional file 1: Table S1 - Summary of the relationships among
curated miRNAs, TFs and target genes.
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